Biogen vet's new startup raises nine-figure round

The company, led by former Biogen and Amgen executive Jo Viney, is pushing into autoimmune diseases with the help of $121 million in new funds.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.